keyword
MENU ▼
Read by QxMD icon Read
search

sternon

keyword
https://www.readbyqxmd.com/read/27369463/book-review
#1
N Lameire, M Lambert, F Roger, C I Michel, J Sternon, J Milaire, M Rooze, S Louryan
No abstract text is available yet for this article.
January 1991: Acta Clinica Belgica
https://www.readbyqxmd.com/read/27237950/traitement-des-infections-bronchopulmonaires-aigues-par-le-laurylsulfate-de-tetracycline-intra-musculaire
#2
J Sternon, J de Hemptinne, R Sergysels, J P Butzler, E Yourassowsky
25 hospitalized patients, suffering from acute bronchopulmonary affections, received every 24 hours, one I.M. injection of 750 mg of tetracycline laurylsulfate (equivalent to 500 mg of tetracycline HCl). Positive clinical results were obtained in all cases. All isolated micro-organisms, sensitive in vitro to tetracycline, were eliminated by this treatment, which produces average tetracycline blood levels close to 2 µg/ml during 24 hours.
January 1972: Acta Clinica Belgica
https://www.readbyqxmd.com/read/25006695/g1-arrested-newborn-cells-are-the-predominant-infectious-form-of-the-pathogen-brucella-abortus
#3
Michaël Deghelt, Caroline Mullier, Jean-François Sternon, Nayla Francis, Géraldine Laloux, Delphine Dotreppe, Charles Van der Henst, Christine Jacobs-Wagner, Jean-Jacques Letesson, Xavier De Bolle
Several intracellular pathogens, such as Brucella abortus, display a biphasic infection process starting with a non-proliferative stage of unclear nature. Here, we study the cell cycle of B. abortus at the single-cell level, in culture and during infection of HeLa cells and macrophages. The localization of segregation and replication loci of the two bacterial chromosomes indicates that, immediately after being engulfed by host-cell endocytic vacuoles, most bacterial cells are newborn. These bacterial cells do not initiate DNA replication for the next 4 to 6 h, indicating a G1 arrest...
2014: Nature Communications
https://www.readbyqxmd.com/read/18265811/-varenicline-an-aid-to-smoking-cessation-therapy
#4
S Perez-Bogerd, J Sternon
Varenicline orally administered nicotine acetylcholine receptor partial agonist is approved by the US FDA and the MEA for use as an aid to smoking cessation therapy. Varenicline is more effective than bupropion but does not reduce weight gain after cessation. The superiority of de varenicline on the nicotine is not demonstrated. Nausea is a frequent adverse effect. The long term safety of varenicline is unknown. The major weapons for smoking cessation are represented by the motivation of the patient and a long term psychotherapy...
November 2007: Revue Médicale de Bruxelles
https://www.readbyqxmd.com/read/17256422/-combination-of-zocor-with-ezetrol
#5
Ph Thibaut, J Sternon
No abstract text is available yet for this article.
November 2006: Revue Médicale de Bruxelles
https://www.readbyqxmd.com/read/17256415/-inhaled-human-insulin-exubera-a-revolution
#6
J C Daubresse, J Sternon
Type 2 diabetes is a step by step process which, at the end, leads to insulin injections. This last step is accomplished in many cases with great delay which increases the risk of micro- and macro-vascular complications. Patients are often reluctant to accept insulin injections and clinicians frequently postpone insulin prescription for many reasons. Any method which could favour more insulin initiation is welcome and this is the case with inhaled insulin. Efficacy has been demonstrated in type 2 and type 1 patients as well as safety if indications are strictly followed by patients and physicians...
November 2006: Revue Médicale de Bruxelles
https://www.readbyqxmd.com/read/17176536/-the-war-on-generic-drugs
#7
EDITORIAL
J Sternon
No abstract text is available yet for this article.
September 2006: Revue Médicale de Bruxelles
https://www.readbyqxmd.com/read/17144644/-pregabalin-lyrica-and-neuropathic-pain-syndromes
#8
J Jacquy, D Lossignol, J Sternon
Pregabalin is a novel central nervous system (CNS) drug with no interaction at benzodiazepine or GABA receptor. Its mechanism of action is correlated with its high affinity for the alpha/delta submit of the voltage-dependant CNS calcium channel. Pregabalin is rapidly absorbed with at least 90% bioavailable irrespective of dose, does not bind to plasma proteins and is excreted virtually unchanged by the kidneys. Pharmacokinetics are linear and predictable across the therapeutic dose range (150-600 mg/ day). Pregabalin is indicated, like gabapentin, in the treatment of neuropathic pain syndromes like post-herpetic neuralgia (PHN) and diabetic polyneuropathy (DPN)...
September 2006: Revue Médicale de Bruxelles
https://www.readbyqxmd.com/read/17058881/-omalizumab-an-anti-ige-monoclonal-antibody-to-treat-severe-asthma
#9
REVIEW
A Michils, J Sternon
Omalizumab (Xolair) is the first representative of a new therapeutical class for severe allergic asthma. By neutralizing Ac IgE, omalizumab fulfils an anti-inflammatory action of which the effect has been shown beneficial in the treatment of severe allergic asthma and particularly in severe asthma for which the therapeutical arsenal is for the time being disappointing and associated to frequent side effects there where omalizumab is well tolerated.
2006: Journal de Pharmacie de Belgique
https://www.readbyqxmd.com/read/16894955/-omalizumab-an-anti-ige-monoclonal-antibody-to-treat-severe-asthma
#10
A Michils, J Sternon
Omalizumab (Xolair) is the first representative of a new therapeutical class, which will be soon available in severe allergic asthma. By neutralizing Ac IgE, omalizumab fulfils an anti-inflammatory action of which the effect has been shown beneficial in the treatment of severe allergic asthma and particularly in severe asthma for which the therapeutical arsenal is for the time being disappointing and associated to frequent side effects there where omalizumab is well tolerated.
May 2006: Revue Médicale de Bruxelles
https://www.readbyqxmd.com/read/16866083/-insulin-analogues-place-of-detemir-levemir
#11
REVIEW
H Dorchy, J Sternon
Insulin detemir (Levemir) is a soluble long-acting human insulin analogue acylated with a 14-carbon fatty acid. Insulin detemir is 98-99% albumin bound in plasma. It has a more predictable glucose-lowering effect than NPH insulin or insulin glargin. There is a dose-response relationship, but at the dose of 0.4 units/kg (an average normal dose), the duration of action reaches nearly 24 h. Therefore, detemir, most often injected once per day at bedtime, seems to be the ideal basal insulin in the basal-prandial therapy for type 1 diabetic patients...
2006: Journal de Pharmacie de Belgique
https://www.readbyqxmd.com/read/16736846/-insulin-analogues-place-of-detemir-levemir
#12
REVIEW
H Dorchy, J Sternon
Insulin detemir (Levemir) is a soluble long-acting human insulin analogue acylated with a 14-carbon fatty acid. Insulin detemir is 98-99% albumin bound in plasma. It has a more predictable glucose-lowering effect than NPH insulin or insulin glargin. There is a dose-response relationship, but at the dose of 0.4 units/ kg (an average normal dose), the duration of action reaches nearly 24 h. Therefore, detemir, most often injected once per day at bedtime, seems to be the ideal basal insulin in the basal-prandial therapy for type 1 diabetic patients...
March 2006: Revue Médicale de Bruxelles
https://www.readbyqxmd.com/read/16608011/-omega-3-fatty-acids-and-cardiovascular-diseases
#13
REVIEW
J C Daubresse, J Sternon
Most--but not all--epidemiological studies have demonstrated that omega-3 intake, either from nutrition or supplementation, reduces cardiovascular risk. A few intervention studies have shown a reduction of studden death in patients followed after a myocardial infarction. However EBM studies from the Cochrane Library do not confirm the real advantage of omega-3 in any group of subjects. Probably, the most interesting prescription of omega-3 supplementations would benefit to the patients after myocardial infarction, in addition to drugs that have proved their efficacy (aspirine, beta-blocker statin and ACE inhibitor)...
January 2006: Revue Médicale de Bruxelles
https://www.readbyqxmd.com/read/16454155/-treatment-of-paget-s-disease-of-bone-with-zoledronic-acid
#14
REVIEW
J J Body, J Sternon
Bone pain and bone deformities are the most common manifestations of Paget's disease of bone, even if the diagnosis is nowadays most often made by chance following a routine measurement of serum alkaline phosphatase. Woven bone is formed following a marked increase in bone resorption due to a stimulation of osteoclast activity. Biphosphonates constitute the modern treatment of Paget's disease of bone. Tiludronate (Skelid), or better risedronate (Actonel), are administered orally every day during at least 2 months...
November 2005: Revue Médicale de Bruxelles
https://www.readbyqxmd.com/read/16252510/-rimonabant-acomplia-specific-inhibitor-of-the-endocannabinoid-system
#15
REVIEW
J Ducobu, J Sternon
The endocannabinoid system plays a major role in the regulation of body energy by stimulation of the appetite in the hypothalamus and increase of fat accumulation in adipocytes. The blockade of the cannabinoid system (CB1) by the specific inhibitor (rimonabant) decreases food intake and adiposity in animals and in humans. Moreover rimonabant lowers tobacco addiction. Clinical studies (RIO-LIPIDS and RIO-EUROPE) have recently confirmed that rimonabant combined with a hypocaloric diet over 1 year, promoted significant decrease of body weight, waist circumference and improvement of dyslipidemia...
2005: Journal de Pharmacie de Belgique
https://www.readbyqxmd.com/read/16038141/-rimonabant-acomplia-specific-inhibitor-of-the-endocannabinoid-system
#16
J Ducobu, J Sternon
The endocannabinoid system plays a major role in the regulation of body energy by stimulation of the appetite in the hypothalamus and increase of fat accumulation in adipocytes. The blockade of the cannabinoid system (CB1) by the specific inhibitor (rimonabant) decreases food intake and adiposity in animals and in humans. Moreover rimonabant lowers tobacco addiction. Clinical studies (RIO-LIPIDS and RIO-EUROPE) have recently confirmed that rimonabant combined with a hypocaloric diet over 1 year, promoted significant decrease of body weight, waist circumference and improvement of dyslipidemia...
May 2005: Revue Médicale de Bruxelles
https://www.readbyqxmd.com/read/15945422/-dutasteride-avodart-a-novel-5-alpha-reductase-inhibitor-for-treatment-of-benign-prostate-hypertrophy
#17
REVIEW
M Vanden Bossche, J Sternon
Dutasteride (Avodart), a novel dual 5-alpha reductase inhibitor is effective for the treatment of benign prostate hypertrophy, of more than 30 cc because the reduction of the level of dihydrotestosterone. By reducing prostatic volume, dutasteride improves moderate to severe symptoms and flow rate. It allows a reduction of disease progression by reducing the rate of acute urinary retention and need for surgery.
March 2005: Revue Médicale de Bruxelles
https://www.readbyqxmd.com/read/15816338/-obesity-in-adult-patients-check-up-and-treatment
#18
J C Daubressse, G B Cadière, J Sternon
Obesity is now one of the major health problems in industrial countries as well as in developing world. Excess caloric intake and reduction of the physical activity are the main causes of obesity. This epidemic precedes a tremendous increase of type 2 diabetes, which is generally linked to weight excess. Obesity and type 2 diabetes are associated with morbidity and mortality and are very expensive for the social security. The important point is to define the risks linked to obesity taking into account the Body Mass Index and the importance of visceral obesity evaluated by waist measurement...
February 2005: Revue Médicale de Bruxelles
https://www.readbyqxmd.com/read/15688892/-antiplatelet-therapy-in-2005
#19
J C Wautrecht, J Sternon
Atherothrombosis is a common physiopathologic process resulting in morbid or fatal ischemic events affecting the cerebral, coronary, or peripheral arterial circulation. Antiplatelet agents are effective in preventing recurrence of vascular events among patients with established vascular disease or with multiple risk factors. Aspirin was the most widely studied antiplatelet drug but the optimal dose remains difficult to define. This article summarizes new data on antiplatelet agents including aspirin, clopidogrel, dipyridamole and glycoprotein IIb/IIIa antagonists with the aim of giving practical recommendations in this very moving field of therapy...
December 2004: Revue Médicale de Bruxelles
https://www.readbyqxmd.com/read/15584647/-ezetimibe-ezetrol-the-statins-partner
#20
REVIEW
J Ducobu, J Sternon
Ezetimibe is a new cholesterol absorption inhibitor that selectively inhibits dietary and biliary cholesterol absorption from the intestine. This drug inhibits cholesterol absorption without affecting the absorption of triglycerides, biliary salts and fat-soluble vitamins. Inhibition of cholesterol absorption using ezetimibe 10 mg/day alone resulted in substantial reductions of plasma LDL-C concentrations (approximately 18%). Coadministration of ezetimibe 10 mg/day with statins 10 mg/day showed LDL lowering comparable to or greater than that of the highest dose of the respective statin alone...
October 2004: Revue Médicale de Bruxelles
keyword
keyword
112315
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"